Puma Biotechnology (PBYI) Insider Trading & Ownership $3.69 +0.40 (+12.16%) Closing price 08/8/2025 04:00 PM EasternExtended Trading$3.68 0.00 (-0.14%) As of 08/8/2025 07:50 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Puma Biotechnology (NASDAQ:PBYI) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage23.30%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)10Amount OfInsider Selling(Last 12 Months)$814.76K Get PBYI Insider Trade Alerts Want to know when executives and insiders are buying or selling Puma Biotechnology stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address PBYI Insider Buying and Selling by Quarter Puma Biotechnology Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails7/18/2025Alessandra CesanoDirectorSell27,000$3.37$90,990.00 7/9/2025Alan H AuerbachCEOSell21,580$3.54$76,393.20 7/9/2025Douglas M HuntInsiderSell3,443$3.54$12,188.22 7/8/2025Alan H AuerbachCEOSell25,592$3.53$90,339.76 7/8/2025Douglas M HuntInsiderSell4,374$3.53$15,440.22 6/13/2025Adrian SenderowiczDirectorSell27,000$3.40$91,800.00 6/13/2025Alessandra CesanoDirectorSell12,150$3.40$41,310.00 6/13/2025Allison DorvalDirectorSell11,610$3.40$39,474.00 6/13/2025Brian M StuglikDirectorSell8,100$3.39$27,459.00 6/13/2025Jay M MoyesDirectorSell22,000$3.40$74,800.00 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 6/13/2025Troy Edward WilsonDirectorSell10,800$3.40$36,720.00 1/2/2025Alan H AuerbachCEOSell33,841$3.15$106,599.15 1/2/2025Jeffrey Jerome LudwigInsiderSell9,437$3.15$29,726.55 8/12/2024Michael Patrick MillerDirectorSell23,358$3.49$81,519.42 (Data available from 1/1/2013 forward) PBYI Insider Trading Activity - Frequently Asked Questions Who is on Puma Biotechnology's Insider Roster? The list of insiders at Puma Biotechnology includes Adrian Senderowicz, Alan H Auerbach, Alessandra Cesano, Allison Dorval, Alvin F Wong, Brian M Stuglik, Douglas M Hunt, Jay M Moyes, Jeffrey Jerome Ludwig, Maximo F Nougues, Michael Patrick Miller, and Troy Edward Wilson. Learn more on insiders at PBYI. What percentage of Puma Biotechnology stock is owned by insiders? 23.30% of Puma Biotechnology stock is owned by insiders. Learn more on PBYI's insider holdings. Which Puma Biotechnology insiders have been selling company stock? The following insiders have sold PBYI shares in the last 24 months: Adrian Senderowicz ($91,800.00), Alan H Auerbach ($602,058.10), Alessandra Cesano ($132,300.00), Allison Dorval ($39,474.00), Alvin F Wong ($34,721.17), Brian M Stuglik ($27,459.00), Douglas M Hunt ($27,628.44), Jay M Moyes ($74,800.00), Jeffrey Jerome Ludwig ($59,125.92), Maximo F Nougues ($103,104.03), Michael Patrick Miller ($152,269.42), and Troy Edward Wilson ($126,630.00). How much insider selling is happening at Puma Biotechnology? Insiders have sold a total of 416,001 Puma Biotechnology shares in the last 24 months for a total of $1,471,370.08 sold. Puma Biotechnology Key ExecutivesMr. Alan H. Auerbach (Age 54)Founder, Chairman, President, CEO & Secretary Compensation: $1.3M2 recent tradesMr. Maximo F. Nougues (Age 55)CFO & Principal Accounting Officer Compensation: $716.2kMr. Douglas Hunt B.Sc. (Age 59)FRAPS, Chief Regulatory Affairs, Medical Affairs, Pharmacovigilance & Law Officer Compensation: $598kMr. Jeffrey Jerome Ludwig (Age 58)Chief Commercial Officer Compensation: $792.57kMr. Mariann OhanesianSenior Director of Investor RelationsDr. Bo H. ChaoSenior Vice President of Clinical Development More Insider Trading Tools from MarketBeat Related Companies ADMA Insider Ownership CTMX Insider Ownership TRDA Insider Ownership ZVRA Insider Ownership PRME Insider Ownership REPL Insider Ownership EOLS Insider Ownership PHAT Insider Ownership KROS Insider Ownership RLAY Insider Ownership Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Strategy Insiders Buy In While Analysts Predict Big UpsideThe Bottom Is in For These 3 Small-Cap Stocks Insiders Are Buying3 Catalysts Driving Plug Power’s Turnaround CaseInsider Selling Hits Market Leaders—Should You Be Worried?Insiders Spent Millions on These 3 Stocks Over the Past 2 Months This page (NASDAQ:PBYI) was last updated on 8/11/2025 by MarketBeat.com Staff From Our PartnersYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Puma Biotechnology, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Puma Biotechnology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access Sale